Armistice Capital’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Armistice Capital’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,419,507	Closed	-$3.58M	–	124
2020 Q2	$3.58M	Hold	1,419,507	–	–	0.16%	69
2020 Q1	$1.82M	Buy	1,419,507 +1,270,000	+849%	+$2.59M	0.11%	70
2019 Q4	$420K	Buy	+149,507	New	+$480K	0.02%	70
2016 Q4	–	Sell	-33,200	Closed	-$2.54M	–	62
2016 Q3	$2.54M	Buy	33,200 +9,096	+38%	+$729K	0.82%	37
2016 Q2	$2.07M	Buy	+24,104	New	+$2.21M	0.79%	38

Armistice Capital's TTPH Position: Q3 2020 in Review

Armistice Capital sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 1,419,507 shares — an estimated $3.58M sold.

Armistice Capital first reported a position in TTPH in Q2 2016 and held it in 5 quarters. The position peaked at $3.58M in Q2 2020. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

Armistice Capital reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Armistice Capital sold 1,419,507 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.58M.
Armistice Capital first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2016 and held it in 5 quarters.
Armistice Capital's Tetraphase Pharmaceuticals, Inc. position peaked at $3.58M in Q2 2020.
1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on Armistice Capital's 13F filing for Q3 2020, filed 16 Nov 2020.